NPI: 1497339667 · MADISONVILLE, KY 42431 · Rural Health Clinic/Center · NPI assigned 05/12/2021
Authorized official CLAY, DANYEL controls 20+ related entities in our dataset. Read more
| Authorized Official | CLAY, DANYEL (EXECUTIVE DIRECTOR REVENUE CYCLE) |
| NPI Enumeration Date | 05/12/2021 |
Other providers sharing the same authorized official: CLAY, DANYEL
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 10,841 | $296K |
| 2023 | 22,630 | $658K |
| 2024 | 16,343 | $581K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,657 | 10,574 | $402K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5,719 | 5,608 | $312K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3,762 | 3,704 | $238K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3,651 | 3,468 | $201K |
| 90461 | 4,186 | 4,093 | $138K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,300 | 1,267 | $76K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,387 | 1,276 | $34K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,833 | 1,291 | $27K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 427 | 403 | $25K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,525 | 1,412 | $21K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 628 | 589 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 685 | 652 | $13K |
| 99381 | 90 | 89 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 358 | 333 | $4K |
| 87807 | 379 | 369 | $4K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 216 | 215 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 54 | 53 | $4K |
| 90677 | 1,004 | 974 | $3K | |
| 87428 | 65 | 60 | $2K | |
| 90670 | 1,535 | 1,507 | $2K | |
| 90723 | 1,765 | 1,727 | $830.96 | |
| 90680 | 1,397 | 1,367 | $658.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16 | 16 | $628.02 |
| 99173 | 106 | 104 | $624.00 | |
| 90474 | 60 | 60 | $490.46 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 29 | 26 | $452.50 |
| 90647 | 1,529 | 1,492 | $206.18 | |
| 90633 | 1,091 | 1,076 | $119.00 | |
| 90716 | 68 | 68 | $113.24 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 81 | 73 | $68.95 |
| 90707 | 56 | 56 | $65.48 | |
| 90686 | 358 | 356 | $28.51 | |
| 90655 | 60 | 60 | $13.80 | |
| 3008F | 1,522 | 1,472 | $1.44 | |
| 2014F | 197 | 188 | $0.14 | |
| 90656 | 60 | 60 | $0.00 | |
| 90697 | 27 | 27 | $0.00 | |
| 90696 | 64 | 63 | $0.00 | |
| 90688 | 42 | 42 | $0.00 | |
| 90651 | 17 | 17 | $0.00 | |
| 90700 | 39 | 38 | $0.00 | |
| 1160F | 284 | 278 | $0.00 | |
| 90687 | 70 | 69 | $0.00 | |
| 1159F | 284 | 278 | $0.00 | |
| 90734 | 25 | 25 | $0.00 | |
| 90710 | 93 | 92 | $0.00 | |
| 90715 | 13 | 13 | $0.00 |